A Study of Orally Administered IPG7236 in Healthy Adult Participants

Clinical trial NCT05288543 · TERMINATED

Trial details

NCT number: NCT05288543
Sponsor: Nanjing Immunophage Biotech Co., Ltd
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2022-04-07
Primary completion: 2023-03-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.